Deepak Roy Sharma

Deepak Roy Sharma

Active Director Director DIN 01637041
DIN 01637041 First appointment Nov 2007 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Nov 2007
Shareholding value •••• Premium profile

About Deepak Roy Sharma

Data last updated:

Deepak Roy Sharma is a Director at Radimage Technologies Private Limited (since 2007) and Director at Cmed Radiology Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹66.63 Cr; the largest is Radimage Technologies Private Limited at ₹33.32 Cr (FY 2025). Earlier, Deepak Roy Sharma was a Director at House Of Diagnostics Healthcare Private Limited (2007–2011) and Director at Ticitech Healthcare Private Limited (2019–2020) and 3 more.

DIN 01637041
Primary Designation Director
Industry Healthcare
First Appointment 06 Nov 2007
Oldest Company Age 19 yrs
Largest company Radimage Technologies Private Limited · ₹33.32 Cr (FY 2025)
Combined revenue ₹66.63 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20072007₹33.32 Cr (FY 2025)Active
Cmed Radiology Private Limited U52100HR2020PTC087613
Director18 Jul 20202020₹33.31 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Dec 20072007₹190 Cr (FY 2025)Active
Ticitech Healthcare Private Limited U85100HR2019PTC079292
Director26 Mar 20192019₹76.3 Lakh (FY 2022)Active
Everx Healthcare Limited U33125DL2010PLC202692
Director14 May 20102010Strike Off
Mrpro Healthcare Private Limited U52609HR2017PTC067052
Director13 Jan 20172017Strike Off
Mriad Healthcare Private Limited U85100HR2011PTC042629
Director08 Apr 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Everx Healthcare Limited
Cmed Radiology Private Limited
Mrpro Healthcare Private Limited
Mriad Healthcare Private Limited
Premium access

Shareholding and investment profile for Deepak Roy Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Roy Sharma

Deepak Roy Sharma currently holds 2 directorships: Radimage Technologies Private Limited (Director, since 06 Nov 2007, revenue ₹33.32 Cr (FY 2025)); Cmed Radiology Private Limited (Director, since 18 Jul 2020, revenue ₹33.31 Cr (FY 2025)).

Deepak Roy Sharma was first appointed on 06 Nov 2007 as Director at Radimage Technologies Private Limited. The most recent appointment on record is 18 Jul 2020 at Cmed Radiology Private Limited.

The 2 current companies of Deepak Roy Sharma that report revenue have a combined latest revenue of ₹66.63 Cr: Radimage Technologies Private Limited ₹33.32 Cr (FY 2025); Cmed Radiology Private Limited ₹33.31 Cr (FY 2025).

Deepak Roy Sharma held 5 earlier board appointments: House Of Diagnostics Healthcare Private Limited (Director, 10 Dec 2007 to 02 Feb 2011); Ticitech Healthcare Private Limited (Director, 26 Mar 2019 to 21 May 2020); Everx Healthcare Limited (Director, from 14 May 2010); Mrpro Healthcare Private Limited (Director, from 13 Jan 2017); Mriad Healthcare Private Limited (Director, from 08 Apr 2011).

The current boards of Deepak Roy Sharma's companies include Balu Macchindra Shinde (Radimage Technologies Private Limited), Kuldeep Kumar Bajpai (Radimage Technologies Private Limited), Atul Kumar Chaturvedi (Cmed Radiology Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available